Skip to main content

Advertisement

SpringerLink
Log in

Necrosome core machinery: MLKL

  • Multi-author review
  • Published:
Cellular and Molecular Life Sciences Aims and scope Submit manuscript

Abstract

In the study of regulated cell death, the rapidly expanding field of regulated necrosis, in particular necroptosis, has been drawing much attention. The signaling of necroptosis represents a sophisticated form of a death pathway. Anti-caspase mechanisms (e.g., using inhibitors of caspases, or genetic ablation of caspase-8) switch cell fate from apoptosis to necroptosis. The initial extracellular death signals regulate RIP1 and RIP3 kinase activation. The RIP3-associated death complex assembly is necessary and sufficient to initiate necroptosis. MLKL was initially identified as an essential mediator of RIP1/RIP3 kinase-initiated necroptosis. Recent studies on the signal transduction using chemical tools and biomarkers support the idea that MLKL is able to make more functional sense for the core machinery of the necroptosis death complex, called the necrosome, to connect to the necroptosis execution. The experimental data available now have pointed that the activated MLKL forms membrane-disrupting pores causing membrane leakage, which extends the prototypical concept of morphological and biochemical events following necroptosis happening in vivo. The key role of MLKL in necroptosis signaling thus sheds light on the logic underlying this unique “membrane-explosive” cell death pathway. In this review, we provide the general concepts and strategies that underlie signal transduction of this form of cell death, and then focus specifically on the role of MLKL in necroptosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kawahara A, Ohsawa Y, Matsumura H, Uchiyama Y, Nagata S (1998) Caspase-independent cell killing by Fas-associated protein with death domain. J Cell Biol 143(5):1353–1360

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Vercammen D, Brouckaert G, Denecker G, Van de Craen M, Declercq W, Fiers W, Vandenabeele P (1998) Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J Exp Med 188(5):919–930

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Vercammen D, Beyaert R, Denecker G, Goossens V, Van Loo G, Declercq W, Grooten J, Fiers W, Vandenabeele P (1998) Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 187(9):1477–1485

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Vercammen D, Vandenabeele P, Beyaert R, Declercq W, Fiers W (1997) Tumour necrosis factor-induced necrosis versus anti-Fas-induced apoptosis in L929 cells. Cytokine 9(11):801–808. doi:10.1006/cyto.1997.0252

    Article  CAS  PubMed  Google Scholar 

  5. Grooten J, Goossens V, Vanhaesebroeck B, Fiers W (1993) Cell membrane permeabilization and cellular collapse, followed by loss of dehydrogenase activity: early events in tumour necrosis factor-induced cytotoxicity. Cytokine 5(6):546–555

    Article  CAS  PubMed  Google Scholar 

  6. Laster SM, Wood JG, Gooding LR (1988) Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J Immunol 141(8):2629–2634

    CAS  PubMed  Google Scholar 

  7. Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B, Tschopp J (2000) Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 1(6):489–495. doi:10.1038/82732

    Article  CAS  PubMed  Google Scholar 

  8. Lee TH, Shank J, Cusson N, Kelliher MA (2004) The kinase activity of Rip1 is not required for tumor necrosis factor-alpha-induced IkappaB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2. J Biol Chem 279(32):33185–33191. doi:10.1074/jbc.M404206200

    Article  CAS  PubMed  Google Scholar 

  9. Ting AT, Pimentel-Muinos FX, Seed B (1996) RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis. EMBO J 15(22):6189–6196

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Hsu H, Huang J, Shu HB, Baichwal V, Goeddel DV (1996) TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4(4):387–396

    Article  CAS  PubMed  Google Scholar 

  11. Grimm S, Stanger BZ, Leder P (1996) RIP and FADD: two “death domain”-containing proteins can induce apoptosis by convergent, but dissociable, pathways. Proc Natl Acad Sci USA 93(20):10923–10927

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, Lin SC, Dong MQ, Han J (2009) RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325(5938):332–336. doi:10.1126/science.1172308

    Article  CAS  PubMed  Google Scholar 

  13. He S, Wang L, Miao L, Wang T, Du F, Zhao L, Wang X (2009) Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 137(6):1100–1111. doi:10.1016/j.cell.2009.05.021

    Article  CAS  PubMed  Google Scholar 

  14. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, Chan FK (2009) Phosphorylation-driven assembly of the RIP1–RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137(6):1112–1123. doi:10.1016/j.cell.2009.05.037

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Sun L, Wang H, Wang Z, He S, Chen S, Liao D, Wang L, Yan J, Liu W, Lei X, Wang X (2012) Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148(1–2):213–227. doi:10.1016/j.cell.2011.11.031

    Article  CAS  PubMed  Google Scholar 

  16. Bertrand MJ, Milutinovic S, Dickson KM, Ho WC, Boudreault A, Durkin J, Gillard JW, Jaquith JB, Morris SJ, Barker PA (2008) cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell 30(6):689–700. doi:10.1016/j.molcel.2008.05.014

    Article  CAS  PubMed  Google Scholar 

  17. Feoktistova M, Geserick P, Kellert B, Dimitrova DP, Langlais C, Hupe M, Cain K, MacFarlane M, Hacker G, Leverkus M (2011) cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 43(3):449–463. doi:10.1016/j.molcel.2011.06.011

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Onizawa M, Oshima S, Schulze-Topphoff U, Oses-Prieto JA, Lu T, Tavares R, Prodhomme T, Duong B, Whang MI, Advincula R, Agelidis A, Barrera J, Wu H, Burlingame A, Malynn BA, Zamvil SS, Ma A (2015) The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis. Nat Immunol. doi:10.1038/ni.3172

    PubMed Central  Google Scholar 

  19. Dillon CP, Oberst A, Weinlich R, Janke LJ, Kang TB, Ben-Moshe T, Mak TW, Wallach D, Green DR (2012) Survival function of the FADD–CASPASE-8–cFLIP(L) complex. Cell Rep 1(5):401–407. doi:10.1016/j.celrep.2012.03.010

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Oberst A, Dillon CP, Weinlich R, McCormick LL, Fitzgerald P, Pop C, Hakem R, Salvesen GS, Green DR (2011) Catalytic activity of the caspase-8–FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471(7338):363–367. doi:10.1038/nature09852

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Wu J, Huang Z, Ren J, Zhang Z, He P, Li Y, Ma J, Chen W, Zhang Y, Zhou X, Yang Z, Wu SQ, Chen L, Han J (2013) Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis. Cell Res 23(8):994–1006. doi:10.1038/cr.2013.91

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Murphy JM, Czabotar PE, Hildebrand JM, Lucet IS, Zhang JG, Alvarez-Diaz S, Lewis R, Lalaoui N, Metcalf D, Webb AI, Young SN, Varghese LN, Tannahill GM, Hatchell EC, Majewski IJ, Okamoto T, Dobson RC, Hilton DJ, Babon JJ, Nicola NA, Strasser A, Silke J, Alexander WS (2013) The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 39(3):443–453. doi:10.1016/j.immuni.2013.06.018

    Article  CAS  PubMed  Google Scholar 

  23. Newton K, Sun X, Dixit VM (2004) Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol Cell Biol 24(4):1464–1469

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Zhang H, Zhou X, McQuade T, Li J, Chan FK, Zhang J (2011) Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 471(7338):373–376. doi:10.1038/nature09878

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Welz PS, Wullaert A, Vlantis K, Kondylis V, Fernandez-Majada V, Ermolaeva M, Kirsch P, Sterner-Kock A, van Loo G, Pasparakis M (2011) FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 477(7364):330–334. doi:10.1038/nature10273

    Article  CAS  PubMed  Google Scholar 

  26. Gunther C, Martini E, Wittkopf N, Amann K, Weigmann B, Neumann H, Waldner MJ, Hedrick SM, Tenzer S, Neurath MF, Becker C (2011) Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis. Nature 477(7364):335–339. doi:10.1038/nature10400

    Article  PubMed  PubMed Central  Google Scholar 

  27. Bonnet MC, Preukschat D, Welz PS, van Loo G, Ermolaeva MA, Bloch W, Haase I, Pasparakis M (2011) The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation. Immunity 35(4):572–582. doi:10.1016/j.immuni.2011.08.014

    Article  CAS  PubMed  Google Scholar 

  28. Rickard JA, O’Donnell JA, Evans JM, Lalaoui N, Poh AR, Rogers T, Vince JE, Lawlor KE, Ninnis RL, Anderton H, Hall C, Spall SK, Phesse TJ, Abud HE, Cengia LH, Corbin J, Mifsud S, Di Rago L, Metcalf D, Ernst M, Dewson G, Roberts AW, Alexander WS, Murphy JM, Ekert PG, Masters SL, Vaux DL, Croker BA, Gerlic M, Silke J (2014) RIPK1 regulates RIPK3–MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 157(5):1175–1188. doi:10.1016/j.cell.2014.04.019

    Article  CAS  PubMed  Google Scholar 

  29. Kaiser WJ, Daley-Bauer LP, Thapa RJ, Mandal P, Berger SB, Huang C, Sundararajan A, Guo H, Roback L, Speck SH, Bertin J, Gough PJ, Balachandran S, Mocarski ES (2014) RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition. Proc Natl Acad Sci USA 111(21):7753–7758. doi:10.1073/pnas.1401857111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Dillon CP, Weinlich R, Rodriguez DA, Cripps JG, Quarato G, Gurung P, Verbist KC, Brewer TL, Llambi F, Gong YN, Janke LJ, Kelliher MA, Kanneganti TD, Green DR (2014) RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 157(5):1189–1202. doi:10.1016/j.cell.2014.04.018

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Newton K, Dugger DL, Wickliffe KE, Kapoor N, de Almagro MC, Vucic D, Komuves L, Ferrando RE, French DM, Webster J, Roose-Girma M, Warming S, Dixit VM (2014) Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science 343(6177):1357–1360. doi:10.1126/science.1249361

    Article  CAS  PubMed  Google Scholar 

  32. Polykratis A, Hermance N, Zelic M, Roderick J, Kim C, Van TM, Lee TH, Chan FK, Pasparakis M, Kelliher MA (2014) Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo. J Immunol 193(4):1539–1543. doi:10.4049/jimmunol.1400590

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Berger SB, Kasparcova V, Hoffman S, Swift B, Dare L, Schaeffer M, Capriotti C, Cook M, Finger J, Hughes-Earle A, Harris PA, Kaiser WJ, Mocarski ES, Bertin J, Gough PJ (2014) Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice. J Immunol 192(12):5476–5480. doi:10.4049/jimmunol.1400499

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Kaiser WJ, Sridharan H, Huang C, Mandal P, Upton JW, Gough PJ, Sehon CA, Marquis RW, Bertin J, Mocarski ES (2013) Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J Biol Chem 288(43):31268–31279. doi:10.1074/jbc.M113.462341

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. He S, Liang Y, Shao F, Wang X (2011) Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc Natl Acad Sci USA 108(50):20054–20059. doi:10.1073/pnas.1116302108

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Ma Y, Temkin V, Liu H, Pope RM (2005) NF-kappaB protects macrophages from lipopolysaccharide-induced cell death: the role of caspase 8 and receptor-interacting protein. J Biol Chem 280(51):41827–41834. doi:10.1074/jbc.M510849200

    Article  CAS  PubMed  Google Scholar 

  37. Upton JW, Kaiser WJ, Mocarski ES (2012) DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe 11(3):290–297. doi:10.1016/j.chom.2012.01.016

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Rebsamen M, Heinz LX, Meylan E, Michallet MC, Schroder K, Hofmann K, Vazquez J, Benedict CA, Tschopp J (2009) DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-kappaB. EMBO Rep 10(8):916–922. doi:10.1038/embor.2009.109

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Mocarski ES, Guo H, Kaiser WJ (2015) Necroptosis: the Trojan horse in cell autonomous antiviral host defense. Virology 479–480:160–166. doi:10.1016/j.virol.2015.03.016

    Article  PubMed  Google Scholar 

  40. Huang Z, Wu SQ, Liang Y, Zhou X, Chen W, Li L, Wu J, Zhuang Q, Chen C, Li J, Zhong CQ, Xia W, Zhou R, Zheng C, Han J (2015) RIP1/RIP3 binding to HSV-1 ICP6 initiates necroptosis to restrict virus propagation in mice. Cell Host Microbe 17(2):229–242. doi:10.1016/j.chom.2015.01.002

    Article  CAS  PubMed  Google Scholar 

  41. Guo H, Omoto S, Harris PA, Finger JN, Bertin J, Gough PJ, Kaiser WJ, Mocarski ES (2015) Herpes simplex virus suppresses necroptosis in human cells. Cell Host Microbe 17(2):243–251. doi:10.1016/j.chom.2015.01.003

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Wang X, Li Y, Liu S, Yu X, Li L, Shi C, He W, Li J, Xu L, Hu Z, Yu L, Yang Z, Chen Q, Ge L, Zhang Z, Zhou B, Jiang X, Chen S, He S (2014) Direct activation of RIP3/MLKL-dependent necrosis by herpes simplex virus 1 (HSV-1) protein ICP6 triggers host antiviral defense. Proc Natl Acad Sci USA 111(43):15438–15443. doi:10.1073/pnas.1412767111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Cook WD, Moujalled DM, Ralph TJ, Lock P, Young SN, Murphy JM, Vaux DL (2014) RIPK1- and RIPK3-induced cell death mode is determined by target availability. Cell Death Differ 21(10):1600–1612. doi:10.1038/cdd.2014.70

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Wu XN, Yang ZH, Wang XK, Zhang Y, Wan H, Song Y, Chen X, Shao J, Han J (2014) Distinct roles of RIP1–RIP3 hetero- and RIP3–RIP3 homo-interaction in mediating necroptosis. Cell Death Differ. doi:10.1038/cdd.2014.77

    Article  Google Scholar 

  45. Orozco S, Yatim N, Werner MR, Tran H, Gunja SY, Tait SW, Albert ML, Green DR, Oberst A (2014) RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis. Cell Death Differ 21(10):1511–1521. doi:10.1038/cdd.2014.76

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Xie T, Peng W, Yan C, Wu J, Gong X, Shi Y (2013) Structural insights into RIP3-mediated necroptotic signaling. Cell reports 5(1):70–78. doi:10.1016/j.celrep.2013.08.044

    Article  CAS  PubMed  Google Scholar 

  47. Li D, Xu T, Cao Y, Wang H, Li L, Chen S, Wang X, Shen Z (2015) A cytosolic heat shock protein 90 and cochaperone CDC37 complex is required for RIP3 activation during necroptosis. Proc Natl Acad Sci USA 112(16):5017–5022. doi:10.1073/pnas.1505244112

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Chen W, Wu J, Li L, Zhang Z, Ren J, Liang Y, Chen F, Yang C, Zhou Z, Sean SuS, Zheng X, Zhang Z, Zhong CQ, Wan H, Xiao M, Lin X, Feng XH, Han J (2015) Ppm1b negatively regulates necroptosis through dephosphorylating Rip3. Nat Cell Biol 17(4):434–444. doi:10.1038/ncb3120

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Rodriguez DA, Weinlich R, Brown S, Guy C, Fitzgerald P, Dillon CP, Oberst A, Quarato G, Low J, Cripps JG, Chen T, Green DR (2015) Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis. Cell Death Differ. doi:10.1038/cdd.2015.70

    Google Scholar 

  50. Wang H, Sun L, Su L, Rizo J, Liu L, Wang LF, Wang FS, Wang X (2014) Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell 54(1):133–146. doi:10.1016/j.molcel.2014.03.003

    Article  CAS  PubMed  Google Scholar 

  51. Liu S, Wang X, Li Y, Xu L, Yu X, Ge L, Li J, Zhu Y, He S (2014) Necroptosis mediates TNF-induced toxicity of hippocampal neurons. Biomed Res Int 2014:290182. doi:10.1155/2014/290182

    PubMed  PubMed Central  Google Scholar 

  52. Ofengeim D, Ito Y, Najafov A, Zhang Y, Shan B, DeWitt JP, Ye J, Zhang X, Chang A, Vakifahmetoglu-Norberg H, Geng J, Py B, Zhou W, Amin P, Berlink Lima J, Qi C, Yu Q, Trapp B, Yuan J (2015) Activation of necroptosis in multiple sclerosis. Cell Rep 10(11):1836–1849. doi:10.1016/j.celrep.2015.02.051

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Blohberger J, Kunz L, Einwang D, Berg U, Berg D, Ojeda SR, Dissen GA, Frohlich T, Arnold GJ, Soreq H, Lara H, Mayerhofer A (2015) Readthrough acetylcholinesterase (AChE-R) and regulated necrosis: pharmacological targets for the regulation of ovarian functions? Cell Death Dis 6:e1685. doi:10.1038/cddis.2015.51

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Degterev A, Hitomi J, Germscheid M, Ch’en IL, Korkina O, Teng X, Abbott D, Cuny GD, Yuan C, Wagner G, Hedrick SM, Gerber SA, Lugovskoy A, Yuan J (2008) Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4(5):313–321. doi:10.1038/nchembio.83

    Article  CAS  PubMed  Google Scholar 

  55. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA, Yuan J (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1(2):112–119. doi:10.1038/nchembio711

    Article  CAS  PubMed  Google Scholar 

  56. Mandal P, Berger SB, Pillay S, Moriwaki K, Huang C, Guo H, Lich JD, Finger J, Kasparcova V, Votta B, Ouellette M, King BW, Wisnoski D, Lakdawala AS, DeMartino MP, Casillas LN, Haile PA, Sehon CA, Marquis RW, Upton J, Daley-Bauer LP, Roback L, Ramia N, Dovey CM, Carette JE, Chan FK, Bertin J, Gough PJ, Mocarski ES, Kaiser WJ (2014) RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol Cell 56(4):481–495. doi:10.1016/j.molcel.2014.10.021

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Hildebrand JM, Tanzer MC, Lucet IS, Young SN, Spall SK, Sharma P, Pierotti C, Garnier JM, Dobson RC, Webb AI, Tripaydonis A, Babon JJ, Mulcair MD, Scanlon MJ, Alexander WS, Wilks AF, Czabotar PE, Lessene G, Murphy JM, Silke J (2014) Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death. Proc Natl Acad Sci USA. doi:10.1073/pnas.1408987111

    PubMed  PubMed Central  Google Scholar 

  58. Chen X, Li W, Ren J, Huang D, He WT, Song Y, Yang C, Li W, Zheng X, Chen P, Han J (2014) Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res 24(1):105–121. doi:10.1038/cr.2013.171

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Cai Z, Jitkaew S, Zhao J, Chiang HC, Choksi S, Liu J, Ward Y, Wu LG, Liu ZG (2014) Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat Cell Biol 16(1):55–65. doi:10.1038/ncb2883

    Article  CAS  PubMed  Google Scholar 

  60. Murphy JM, Lucet IS, Hildebrand JM, Tanzer MC, Young SN, Sharma P, Lessene G, Alexander WS, Babon JJ, Silke J, Czabotar PE (2014) Insights into the evolution of divergent nucleotide-binding mechanisms among pseudokinases revealed by crystal structures of human and mouse MLKL. Biochem J 457(3):369–377. doi:10.1042/BJ20131270

    Article  CAS  PubMed  Google Scholar 

  61. Rameh LE, Arvidsson A, Carraway KL 3rd, Couvillon AD, Rathbun G, Crompton A, VanRenterghem B, Czech MP, Ravichandran KS, Burakoff SJ, Wang DS, Chen CS, Cantley LC (1997) A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains. J Biol Chem 272(35):22059–22066

    Article  CAS  PubMed  Google Scholar 

  62. Marte BM, Downward J (1997) PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem Sci 22(9):355–358

    Article  CAS  PubMed  Google Scholar 

  63. Salim K, Bottomley MJ, Querfurth E, Zvelebil MJ, Gout I, Scaife R, Margolis RL, Gigg R, Smith CI, Driscoll PC, Waterfield MD, Panayotou G (1996) Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton’s tyrosine kinase. EMBO J 15(22):6241–6250

    CAS  PubMed  PubMed Central  Google Scholar 

  64. Garcia P, Gupta R, Shah S, Morris AJ, Rudge SA, Scarlata S, Petrova V, McLaughlin S, Rebecchi MJ (1995) The pleckstrin homology domain of phospholipase C-delta 1 binds with high affinity to phosphatidylinositol 4,5-bisphosphate in bilayer membranes. Biochemistry 34(49):16228–16234

    Article  CAS  PubMed  Google Scholar 

  65. Dondelinger Y, Declercq W, Montessuit S, Roelandt R, Goncalves A, Bruggeman I, Hulpiau P, Weber K, Sehon CA, Marquis RW, Bertin J, Gough PJ, Savvides S, Martinou JC, Bertrand MJ, Vandenabeele P (2014) MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep 7(4):971–981. doi:10.1016/j.celrep.2014.04.026

    Article  CAS  PubMed  Google Scholar 

  66. van Meer G, de Kroon AI (2011) Lipid map of the mammalian cell. J Cell Sci 124(Pt 1):5–8. doi:10.1242/jcs.071233

    Article  PubMed  Google Scholar 

  67. van Meer G, Voelker DR, Feigenson GW (2008) Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol 9(2):112–124. doi:10.1038/nrm2330

    Article  PubMed  PubMed Central  Google Scholar 

  68. Sorice M, Manganelli V, Matarrese P, Tinari A, Misasi R, Malorni W, Garofalo T (2009) Cardiolipin-enriched raft-like microdomains are essential activating platforms for apoptotic signals on mitochondria. FEBS Lett 583(15):2447–2450. doi:10.1016/j.febslet.2009.07.018

    Article  CAS  PubMed  Google Scholar 

  69. Sorice M, Circella A, Cristea IM, Garofalo T, Di Renzo L, Alessandri C, Valesini G, Esposti MD (2004) Cardiolipin and its metabolites move from mitochondria to other cellular membranes during death receptor-mediated apoptosis. Cell Death Differ 11(10):1133–1145. doi:10.1038/sj.cdd.4401457

    Article  CAS  PubMed  Google Scholar 

  70. Stepanyants N, Macdonald PJ, Francy CA, Mears JA, Qi X, Ramachandran R (2015) Cardiolipin’s propensity for phase transition and its reorganization by dynamin-related protein 1 form a basis for mitochondrial membrane fission. Mol Biol Cell 26(17):3104–3116. doi:10.1091/mbc.E15-06-0330

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Kaczmarek A, Vandenabeele P, Krysko DV (2013) Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 38(2):209–223. doi:10.1016/j.immuni.2013.02.003

    Article  CAS  PubMed  Google Scholar 

  72. Su L, Quade B, Wang H, Sun L, Wang X, Rizo J (2014) A plug release mechanism for membrane permeation by MLKL. Structure. doi:10.1016/j.str.2014.07.014

    Google Scholar 

  73. Quarato G, Guy CS, Grace CR, Llambi F, Nourse A, Rodriguez DA, Wakefield R, Frase S, Moldoveanu T, Green DR (2016) Sequential engagement of distinct MLKL phosphatidylinositol-binding sites executes necroptosis. Mol Cell. doi:10.1016/j.molcel.2016.01.011

    PubMed  Google Scholar 

  74. Gouaux E (1997) Channel-forming toxins: tales of transformation. Curr Opin Struct Biol 7(4):566–573

    Article  CAS  PubMed  Google Scholar 

  75. Lesieur C, Vecsey-Semjen B, Abrami L, Fivaz M, Gisou van der Goot F (1997) Membrane insertion: the strategies of toxins (review). Mol Membr Biol 14(2):45–64

    Article  CAS  PubMed  Google Scholar 

  76. Mueller M, Grauschopf U, Maier T, Glockshuber R, Ban N (2009) The structure of a cytolytic alpha-helical toxin pore reveals its assembly mechanism. Nature 459(7247):726–730. doi:10.1038/nature08026

    Article  CAS  PubMed  Google Scholar 

  77. Gilbert RJ, Mikelj M, Dalla Serra M, Froelich CJ, Anderluh G (2013) Effects of MACPF/CDC proteins on lipid membranes. Cell Mol Life Sci 70(12):2083–2098. doi:10.1007/s00018-012-1153-8

    Article  CAS  PubMed  Google Scholar 

  78. Shatursky O, Heuck AP, Shepard LA, Rossjohn J, Parker MW, Johnson AE, Tweten RK (1999) The mechanism of membrane insertion for a cholesterol-dependent cytolysin: a novel paradigm for pore-forming toxins. Cell 99(3):293–299

    Article  CAS  PubMed  Google Scholar 

  79. Tweten RK, Hotze EM, Wade KR (2015) The unique molecular choreography of giant pore formation by the cholesterol-dependent cytolysins of Gram-positive bacteria. Annu Rev Microbiol 69:323–340. doi:10.1146/annurev-micro-091014-104233

    Article  CAS  PubMed  Google Scholar 

  80. Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT (2015) Complement system part I—molecular mechanisms of activation and regulation. Front Immunol 6:262. doi:10.3389/fimmu.2015.00262

    PubMed  PubMed Central  Google Scholar 

  81. Merle NS, Noe R, Halbwachs-Mecarelli L, Fremeaux-Bacchi V, Roumenina LT (2015) Complement system part II: role in immunity. Front Immunol 6:257. doi:10.3389/fimmu.2015.00257

    PubMed  PubMed Central  Google Scholar 

  82. Aleshin AE, Schraufstatter IU, Stec B, Bankston LA, Liddington RC, DiScipio RG (2012) Structure of complement C6 suggests a mechanism for initiation and unidirectional, sequential assembly of membrane attack complex (MAC). J Biol Chem 287(13):10210–10222. doi:10.1074/jbc.M111.327809

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Aleshin AE, DiScipio RG, Stec B, Liddington RC (2012) Crystal structure of C5b-6 suggests structural basis for priming assembly of the membrane attack complex. J Biol Chem 287(23):19642–19652. doi:10.1074/jbc.M112.361121

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Voskoboinik I, Dunstone MA, Baran K, Whisstock JC, Trapani JA (2010) Perforin: structure, function, and role in human immunopathology. Immunol Rev 235(1):35–54. doi:10.1111/j.0105-2896.2010.00896.x

    Article  CAS  PubMed  Google Scholar 

  85. Voskoboinik I, Whisstock JC, Trapani JA (2015) Perforin and granzymes: function, dysfunction and human pathology. Nat Rev Immunol. doi:10.1038/nri3839

    PubMed  Google Scholar 

  86. Tschopp J, Masson D, Stanley KK (1986) Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis. Nature 322(6082):831–834. doi:10.1038/322831a0

    Article  CAS  PubMed  Google Scholar 

  87. Law RH, Lukoyanova N, Voskoboinik I, Caradoc-Davies TT, Baran K, Dunstone MA, D’Angelo ME, Orlova EV, Coulibaly F, Verschoor S, Browne KA, Ciccone A, Kuiper MJ, Bird PI, Trapani JA, Saibil HR, Whisstock JC (2010) The structural basis for membrane binding and pore formation by lymphocyte perforin. Nature 468(7322):447–451. doi:10.1038/nature09518

    Article  CAS  PubMed  Google Scholar 

  88. Voskoboinik I, Whisstock JC, Trapani JA (2015) Perforin and granzymes: function, dysfunction and human pathology. Nat Rev Immunol 15(6):388–400. doi:10.1038/nri3839

    Article  CAS  PubMed  Google Scholar 

  89. Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, Zhuang Y, Cai T, Wang F, Shao F (2015) Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526(7575):660–665. doi:10.1038/nature15514

    Article  CAS  PubMed  Google Scholar 

  90. Kayagaki N, Stowe IB, Lee BL, O’Rourke K, Anderson K, Warming S, Cuellar T, Haley B, Roose-Girma M, Phung QT, Liu PS, Lill JR, Li H, Wu J, Kummerfeld S, Zhang J, Lee WP, Snipas SJ, Salvesen GS, Morris LX, Fitzgerald L, Zhang Y, Bertram EM, Goodnow CC, Dixit VM (2015) Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526(7575):666–671. doi:10.1038/nature15541

    Article  CAS  PubMed  Google Scholar 

  91. Yoon S, Bogdanov K, Kovalenko A, Wallach D (2015) Necroptosis is preceded by nuclear translocation of the signaling proteins that induce it. Cell Death Differ. doi:10.1038/cdd.2015.92

    PubMed Central  Google Scholar 

Download references

Acknowledgments

We thank Ms. Sasha Sa for critical reading and comments on the manuscript. The work of L.S. is sponsored by Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and The One Hundred Talents Program of Chinese Academy of Sciences.

Author information

Authors and Affiliations

  1. State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue Yang Rd, Shanghai, 200031, China

    Jing Zhang, Yu Yang, Wenyan He & Liming Sun

Authors
  1. Jing Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yu Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wenyan He
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Liming Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Liming Sun.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, J., Yang, Y., He, W. et al. Necrosome core machinery: MLKL. Cell. Mol. Life Sci. 73, 2153–2163 (2016). https://doi.org/10.1007/s00018-016-2190-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-016-2190-5

Keywords

Search

Navigation